Nutromics
PrivateLast Round
Acceleration Round
Sep 2, 2025
Total Funding Raised
$18.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nutromics is a healthtech company that develops a wearable diagnostic platform featuring DNA-based sensors and microneedles for continuous, real-time monitoring of molecular biomarkers and therapeutic drugs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nutromics Comparables
Compare Nutromics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adaptyx Biosciences | 84% | |
| Aptec Health | 79% | |
| KitechDx | 78% |
Nutromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Acceleration Round | Sep 2, 2025 | ||||
| Grant | Apr 27, 2024 | ||||
| VC Round | Jun 8, 2023 | ||||
| Seed | Sep 8, 2022 | ||||
| Grant | Sep 29, 2021 | ||||
Seed | Aug 27, 2021 |
Key People
Founding team and executive leadership
Nutromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| The Actuator | Pre Seed |
| Dexcom Ventures | Seed |
| Artesian | Pre Seed, Seed |
| VU Venture Partners | Seed |
| Australian Federal Government (Cooperative Research Centres Projects grant) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 114% MoM.
- Jul 24, 2026
Monthly visitors increased 43% MoM, reaching 2K.
Recent news
Latest coverage and updates
- is_developingSep 18, 2026
Nutromics is developing world-first wearable microneedle patch for real-time sepsis management on Sep 1st '26.
- receives_financingSep 18, 2026
Nutromics received financing of $3M in CRC-P funding on Sep 1st '26.
- hiresSep 7, 2026
Nutromics hired Kevin W. Plaxco as Chief Scientific Officer on Sep 7th '26.
Nutromics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nutromics's valuation, stock price, and market status.
Is Nutromics a public or private company?
Nutromics is a private company.
What is the current stock price of Nutromics?
Nutromics is a private company with no public stock price. No recent secondary market data is available.
How much is Nutromics worth (valuation)?
Valuation information for Nutromics is not publicly available.
Can I buy Nutromics stock?
Nutromics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nutromics's last funding round?
Nutromics's most recent funding round was Acceleration Round on September 2, 2025.
Who are the main investors in Nutromics?
Key investors in Nutromics include The Actuator, Dexcom Ventures, Artesian, VU Venture Partners.
Will Nutromics IPO soon?
No public IPO plans have been announced for Nutromics.
How can I track Nutromics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nutromics's secondary market activity and sign up for updates.